Free shipping on all orders over $ 500

Necrostatin-5

Cat. No. M7942

All AbMole products are for research use only, cannot be used for human consumption.

Necrostatin-5 Structure
Size Price Availability Quantity
5mg USD 50  USD50 In stock
10mg USD 80  USD80 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Necrostatin-5 is an inhibitor of necroptosis (non-apoptotic cell death pathway) by indirect inhibition of RIP1 kinase. Necroptosis is defined as alternative active cell death pathway: Death-Domain Receptor (DRs, e.g. Fas/TNFR) mediated and caspase-inhibitor insensitive with specific morphology (nuclear condensation, organelle swelling, loss of plasma membrane integrity). The necrostatins have been discovered to inhibit this pathway by inhibition of the death domain receptor-associated adaptor kinase RIP1. Three distinct mechanisms appear to be involved: T-loop dependent inhibition by necrostatin-1; partially T-loop independent inhibition by necrostatin-3 and indirect inhibition of RIP1 by necrostatin-5, since necrostatin-5 is a potent inhibitor of immunnoprecipitated RIP1, but does not inhibit recombinant RIP1.

Chemical Information
Molecular Weight 383.49
Formula C19H17N3O2S2
CAS Number 337349-54-9
Solubility (25°C) DMSO: ≥10 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Ryan P Gilley, et al. Infiltrated Macrophages Die of Pneumolysin-Mediated Necroptosis following Pneumococcal Myocardial Invasion

[2] Norberto Gonzlez-Juarbe, et al. Pore-Forming Toxins Induce Macrophage Necroptosis during Acute Bacterial Pneumonia

[3] Yu V Dmitriev, et al. Study of cardioprotective effects of necroptosis inhibitors on isolated rat heart subjected to global ischemia-reperfusion

[4] Alexei Degterev, et al. Identification of RIP1 kinase as a specific cellular target of necrostatins

[5] Ke Wang, et al. Structure-activity relationship analysis of a novel necroptosis inhibitor, Necrostatin-5

Related RIPK Products
RIP1/RIP3/MLKL activator 1

RIP1/RIP3/MLKL activator 1 is a potent, blood-brain barrier permeable anti-glioma agent. RIP1/RIP3/MLKL activator 1 induces necroptosis through RIP1/RIP3/MLKL pathway.

Oditrasertib 

Oditrasertib is a receptor-interacting protein kinase 1 (RIPK1) inhibitor with an IC50 value lower than 100 nM.

OD36 hydrochloride 

OD36hydrochloride is a RIPK2 inhibitor with an IC50 of 5.3 nM.

RIPK1-IN-12

RIPK1-IN-12 is a potent RIPK1 inhibitor.

DNL747

DNL747 is an ASK1 and RIPK1 inhibitor for studies related to Alzheimer's disease, amyotrophic lateral sclerosis, and multiple sclerosis.

  Catalog
Abmole Inhibitor Catalog




Keywords: Necrostatin-5 supplier, RIPK, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.